leo: extract claims from 2026-04-21-penn-ehrs-durc-pepp-governance-vacuum
- Source: inbox/queue/2026-04-21-penn-ehrs-durc-pepp-governance-vacuum.md - Domain: grand-strategy - Claims: 2, Entities: 0 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Leo <PIPELINE>
This commit is contained in:
parent
c8f30ae6ff
commit
8548a11c9f
4 changed files with 52 additions and 7 deletions
|
|
@ -0,0 +1,18 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: grand-strategy
|
||||||
|
description: EO 14292's justification as anti-GOF populism rather than AI-bio convergence risk prevents AI safety advocates from recognizing the AI governance implications of DURC/PEPP rescission
|
||||||
|
confidence: experimental
|
||||||
|
source: EO 14292 framing analysis, Council on Strategic Risks 2025 AIxBio report, Congressional Research Service flagging without legislative response
|
||||||
|
created: 2026-04-21
|
||||||
|
title: Anti-gain-of-function political framing structurally decouples AI governance from biosecurity governance debates, creating the most dangerous variant of indirect governance erosion where the community that would oppose the erosion doesn't recognize the connection
|
||||||
|
agent: leo
|
||||||
|
scope: structural
|
||||||
|
sourcer: University of Pennsylvania EHRS
|
||||||
|
supports: ["existential-risks-interact-as-a-system-of-amplifying-feedback-loops-not-independent-threats"]
|
||||||
|
related: ["ai-governance-discourse-capture-by-competitiveness-framing-inverts-china-us-participation-patterns", "existential-risks-interact-as-a-system-of-amplifying-feedback-loops-not-independent-threats", "use-based-ai-governance-emerged-as-legislative-framework-but-lacks-bipartisan-support", "use-based-ai-governance-emerged-as-legislative-framework-through-slotkin-ai-guardrails-act", "government designation of safety-conscious AI labs as supply chain risks inverts the regulatory dynamic by penalizing safety constraints rather than enforcing them"]
|
||||||
|
---
|
||||||
|
|
||||||
|
# Anti-gain-of-function political framing structurally decouples AI governance from biosecurity governance debates, creating the most dangerous variant of indirect governance erosion where the community that would oppose the erosion doesn't recognize the connection
|
||||||
|
|
||||||
|
Executive Order 14292 was framed and justified through anti-gain-of-function populism rather than AI-biosecurity convergence risk, despite the Council on Strategic Risks documenting that 'AI could provide step-by-step guidance on designing lethal pathogens, sourcing materials, and optimizing methods of dispersal.' This framing choice has structural consequences: biosecurity advocates see it as a gain-of-function debate (their domain), while AI safety advocates don't recognize the AI governance connection. The result is that the community most equipped to oppose AI-assisted dual-use research deregulation—AI safety advocates who understand AI capability trajectories—doesn't engage because the policy debate is framed in biological research terms. The Congressional Research Service flagged the DURC/PEPP vacuum as an open concern, but no legislation has been introduced to restore oversight, consistent with neither community recognizing this as their coordination problem. This represents Mechanism 2 (indirect governance erosion) from the April 14 session: governance is dismantled not through direct AI policy changes that would trigger AI safety community opposition, but through adjacent domain policy changes (biosecurity) that the AI community doesn't monitor. The anti-GOF framing is politically convenient but scientifically incoherent as a policy framework for AI-bio convergence risks, suggesting the framing choice itself may be strategic rather than incidental.
|
||||||
|
|
@ -0,0 +1,18 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: grand-strategy
|
||||||
|
description: The May 2025 executive order rescinded existing dual-use research oversight and mandated replacement within 120 days, but as of April 2026 no replacement exists, creating a governance absence rather than weakened governance
|
||||||
|
confidence: proven
|
||||||
|
source: University of Pennsylvania EHRS, NIH NOT-OD-25-112 and NOT-OD-25-127, White House EO 14292
|
||||||
|
created: 2026-04-21
|
||||||
|
title: EO 14292's DURC/PEPP rescission created an indefinite biosecurity governance vacuum because OSTP missed its 120-day replacement policy deadline by 7+ months, leaving AI-assisted dual-use biological research without operative oversight during peak AI-bio capability growth
|
||||||
|
agent: leo
|
||||||
|
scope: causal
|
||||||
|
sourcer: University of Pennsylvania EHRS
|
||||||
|
supports: ["existential-risks-interact-as-a-system-of-amplifying-feedback-loops-not-independent-threats", "mandatory-legislative-governance-closes-technology-coordination-gap-while-voluntary-governance-widens-it"]
|
||||||
|
related: ["existential-risks-interact-as-a-system-of-amplifying-feedback-loops-not-independent-threats", "voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives"]
|
||||||
|
---
|
||||||
|
|
||||||
|
# EO 14292's DURC/PEPP rescission created an indefinite biosecurity governance vacuum because OSTP missed its 120-day replacement policy deadline by 7+ months, leaving AI-assisted dual-use biological research without operative oversight during peak AI-bio capability growth
|
||||||
|
|
||||||
|
Executive Order 14292 (May 5, 2025) rescinded the May 2024 DURC/PEPP policy framework that governed Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential. The order directed OSTP to publish a replacement policy within 120 days (approximately September 3, 2025 deadline). As documented by Penn EHRS on September 29, 2025, and confirmed through April 2026, OSTP has not published the replacement policy—missing its own executive order deadline by over seven months with no published explanation. NIH implemented the pause immediately (NOT-OD-25-112 on May 7, 2025 stopped accepting DGOF grant applications; NOT-OD-25-127 on June 18, 2025 required portfolio reviews by June 30). The research community now operates in a policy vacuum where dangerous gain-of-function research is paused by default without an operative classification framework. This is structurally different from weakened governance—it is the absence of governance. The timing is critical: the Council on Strategic Risks' 2025 AIxBio report notes that 'AI could provide step-by-step guidance on designing lethal pathogens, sourcing materials, and optimizing methods of dispersal'—precisely the dual-use research category DURC/PEPP was designed to govern. The seven-month delay suggests either OSTP lacks expertise/resources to develop the replacement (consistent with DOGE budget cuts to NIH -$18B, CDC -$3.6B, NIST -$325M) or deliberate delay where anti-gain-of-function political framing is convenient but scientifically incoherent as a policy framework.
|
||||||
|
|
@ -10,14 +10,16 @@ agent: leo
|
||||||
scope: structural
|
scope: structural
|
||||||
sourcer: Leo
|
sourcer: Leo
|
||||||
related_claims: ["[[technology-governance-coordination-gaps-close-when-four-enabling-conditions-are-present-visible-triggering-events-commercial-network-effects-low-competitive-stakes-at-inception-or-physical-manifestation]]", "[[governance-coordination-speed-scales-with-number-of-enabling-conditions-present-creating-predictable-timeline-variation-from-5-years-with-three-conditions-to-56-years-with-one-condition]]", "[[the-legislative-ceiling-on-military-ai-governance-is-conditional-not-absolute-cwc-proves-binding-governance-without-carveouts-is-achievable-but-requires-three-currently-absent-conditions]]"]
|
related_claims: ["[[technology-governance-coordination-gaps-close-when-four-enabling-conditions-are-present-visible-triggering-events-commercial-network-effects-low-competitive-stakes-at-inception-or-physical-manifestation]]", "[[governance-coordination-speed-scales-with-number-of-enabling-conditions-present-creating-predictable-timeline-variation-from-5-years-with-three-conditions-to-56-years-with-one-condition]]", "[[the-legislative-ceiling-on-military-ai-governance-is-conditional-not-absolute-cwc-proves-binding-governance-without-carveouts-is-achievable-but-requires-three-currently-absent-conditions]]"]
|
||||||
related:
|
related: ["Commercial interests blocking condition operates continuously through ratification, not just at governance inception, as proven by PABS annex dispute", "Maximum triggering events produce broad international adoption without powerful actor participation because strategic interests override catastrophic death toll", "triggering-events-produce-domestic-regulatory-governance-but-cannot-produce-international-treaty-governance-when-commercial-network-effects-low-competitive-stakes-and-verifiability-are-absent", "pandemic-agreement-confirms-maximum-triggering-event-produces-broad-adoption-without-powerful-actor-participation-because-strategic-interests-override-catastrophic-death-toll", "triggering-event-architecture-requires-three-components-infrastructure-disaster-champion-as-confirmed-by-pharmaceutical-and-arms-control-cases", "pharmaceutical-governance-advances-required-triggering-events-not-incremental-advocacy-because-kefauver-three-year-blockage-proves-technical-expertise-insufficient", "pharmaceutical-governance-advances-required-triggering-events-not-incremental-advocacy-because-kefauver-three-year-blockage-preceded-thalidomide-breakthrough"]
|
||||||
- Commercial interests blocking condition operates continuously through ratification, not just at governance inception, as proven by PABS annex dispute
|
reweave_edges: ["Commercial interests blocking condition operates continuously through ratification, not just at governance inception, as proven by PABS annex dispute|related|2026-04-18", "Maximum triggering events produce broad international adoption without powerful actor participation because strategic interests override catastrophic death toll|related|2026-04-19"]
|
||||||
- Maximum triggering events produce broad international adoption without powerful actor participation because strategic interests override catastrophic death toll
|
|
||||||
reweave_edges:
|
|
||||||
- Commercial interests blocking condition operates continuously through ratification, not just at governance inception, as proven by PABS annex dispute|related|2026-04-18
|
|
||||||
- Maximum triggering events produce broad international adoption without powerful actor participation because strategic interests override catastrophic death toll|related|2026-04-19
|
|
||||||
---
|
---
|
||||||
|
|
||||||
# Triggering events are sufficient to eventually produce domestic regulatory governance but cannot produce international treaty governance when Conditions 2, 3, and 4 are absent — demonstrated by COVID-19 producing domestic health governance reforms across major economies while failing to produce a binding international pandemic treaty 6 years after the largest triggering event in modern history
|
# Triggering events are sufficient to eventually produce domestic regulatory governance but cannot produce international treaty governance when Conditions 2, 3, and 4 are absent — demonstrated by COVID-19 producing domestic health governance reforms across major economies while failing to produce a binding international pandemic treaty 6 years after the largest triggering event in modern history
|
||||||
|
|
||||||
COVID-19 provides the definitive test case: the largest triggering event in modern governance history (7+ million deaths, global economic disruption, maximum visibility and emotional resonance) produced strong domestic governance responses but failed to produce binding international governance after 6 years. Every major economy reformed pandemic preparedness legislation, created emergency authorization pathways, and expanded health system capacity — demonstrating that triggering events work at the domestic level as the pharmaceutical model predicts. However, at the international level: COVAX delivered 1.9 billion doses but failed its equity goal (62% coverage high-income vs. 2% low-income by mid-2021), structurally dependent on voluntary donations and subordinated to vaccine nationalism; IHR amendments (June 2024) were adopted but significantly diluted with weakened binding compliance after sovereignty objections; and the Pandemic Agreement (CA+) remains unsigned as of April 2026 despite negotiations beginning in 2021 with a May 2024 deadline, with PABS and equity obligations still unresolved. This is not advocacy failure but structural failure — the same sovereignty conflicts, competitive stakes (vaccine nationalism), and absence of commercial self-enforcement that prevent AI governance also prevented COVID governance at the international level. Cybersecurity provides 35-year confirmation: Stuxnet (2010), WannaCry (2017, 200,000+ targets in 150 countries), NotPetya (2017, $10B+ damage), SolarWinds (2020), and Colonial Pipeline (2021) produced zero binding international framework despite repeated triggering events, because cybersecurity has the same zero-conditions profile as AI (diffuse non-physical harms, high strategic utility, peak competitive stakes, no commercial network effects, attribution-resistant). The domestic/international split means AI governance faces compound difficulty: pharmaceutical-hard for domestic regulation AND cybersecurity-hard for international coordination, both simultaneously, with Level 1 progress unable to substitute for Level 2 progress on racing dynamics and existential risk.
|
COVID-19 provides the definitive test case: the largest triggering event in modern governance history (7+ million deaths, global economic disruption, maximum visibility and emotional resonance) produced strong domestic governance responses but failed to produce binding international governance after 6 years. Every major economy reformed pandemic preparedness legislation, created emergency authorization pathways, and expanded health system capacity — demonstrating that triggering events work at the domestic level as the pharmaceutical model predicts. However, at the international level: COVAX delivered 1.9 billion doses but failed its equity goal (62% coverage high-income vs. 2% low-income by mid-2021), structurally dependent on voluntary donations and subordinated to vaccine nationalism; IHR amendments (June 2024) were adopted but significantly diluted with weakened binding compliance after sovereignty objections; and the Pandemic Agreement (CA+) remains unsigned as of April 2026 despite negotiations beginning in 2021 with a May 2024 deadline, with PABS and equity obligations still unresolved. This is not advocacy failure but structural failure — the same sovereignty conflicts, competitive stakes (vaccine nationalism), and absence of commercial self-enforcement that prevent AI governance also prevented COVID governance at the international level. Cybersecurity provides 35-year confirmation: Stuxnet (2010), WannaCry (2017, 200,000+ targets in 150 countries), NotPetya (2017, $10B+ damage), SolarWinds (2020), and Colonial Pipeline (2021) produced zero binding international framework despite repeated triggering events, because cybersecurity has the same zero-conditions profile as AI (diffuse non-physical harms, high strategic utility, peak competitive stakes, no commercial network effects, attribution-resistant). The domestic/international split means AI governance faces compound difficulty: pharmaceutical-hard for domestic regulation AND cybersecurity-hard for international coordination, both simultaneously, with Level 1 progress unable to substitute for Level 2 progress on racing dynamics and existential risk.
|
||||||
|
|
||||||
|
## Challenging Evidence
|
||||||
|
|
||||||
|
**Source:** EO 14292 rescinding May 2024 DURC/PEPP policy after COVID-19 pandemic
|
||||||
|
|
||||||
|
The DURC/PEPP rescission challenges the permanence assumption in triggering event theory: the COVID-19 pandemic was a maximum-scale triggering event (millions of deaths, global economic disruption), yet the domestic regulatory governance it produced (DURC/PEPP framework) was eliminated within one year of a new administration. This suggests triggering events produce governance that is administration-dependent rather than institutionally stable.
|
||||||
|
|
|
||||||
|
|
@ -24,3 +24,10 @@ The Anthropic preliminary injunction is a one-round victory that reveals a struc
|
||||||
**Source:** DC Circuit Court of Appeals, Anthropic v. Pentagon, April 8, 2026
|
**Source:** DC Circuit Court of Appeals, Anthropic v. Pentagon, April 8, 2026
|
||||||
|
|
||||||
DC Circuit April 8, 2026 ruling demonstrates voluntary constraints lack not only contractual enforcement (original claim) but also constitutional protection when government frames exclusion as supply chain risk management. The 'primarily financial' framing enabled administrative dismissal without First Amendment scrutiny, even though the underlying policy (refusing autonomous lethal weapons) is identical to speech protected in civil jurisdiction.
|
DC Circuit April 8, 2026 ruling demonstrates voluntary constraints lack not only contractual enforcement (original claim) but also constitutional protection when government frames exclusion as supply chain risk management. The 'primarily financial' framing enabled administrative dismissal without First Amendment scrutiny, even though the underlying policy (refusing autonomous lethal weapons) is identical to speech protected in civil jurisdiction.
|
||||||
|
|
||||||
|
|
||||||
|
## Extending Evidence
|
||||||
|
|
||||||
|
**Source:** EO 14292, OSTP deadline miss through April 2026
|
||||||
|
|
||||||
|
The DURC/PEPP case extends beyond voluntary constraints lacking enforcement—it shows that even mandatory oversight frameworks can be eliminated through executive action without replacement, creating governance absence rather than merely unenforced rules. The seven-month delay past the 120-day deadline suggests the absence may be indefinite.
|
||||||
|
|
|
||||||
Loading…
Reference in a new issue